Shaw P., Lerch J. P., Pruessner J., Taylor K. N., Rose A. B., Greenstein D., Clasen L., Evans A., Rapoport J. L., Giedd J. N. (2007). Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study, Lancet Neurol, 6(6), 494-500.

Vellas B., Andrieu S., Cantet C., Dartigues J. F., Gauthier S. (2007). Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?, J Nutr Health Aging, 11(4), 338-41.

Vercauteren F. G., Arckens L., Quirion R. (2007). Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis, Amino Acids, 33(3), 405-14.

Vercauteren F. G., Flores C., Ma W., Chabot J. G., Geenen L., Clerens S., Fazel A., Bergeron J. J., Srivastava L., Arckens L., Quirion R. (2007). An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia, Proteomics, 7(19), 3569-79.

Walker C., Long H., Williams S., Richard D. (2007). Long-lasting effects of elevated neonatal leptin on rat hippocampal function, synaptic proteins and NMDA receptor subunits, J Neurosci Res, 85(4), 816-828.

Allain H., Bentue-Ferrer D., Vellas B., Gauthier S. (2006). Pharmacothérapeutique des démences sévères, L’Année Gérontologique, 20, Serdi, Paris, 84-91.

, Danik M., Mennicken F., Williams S., Quirion R. (2006). Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation, BMC Neurosci, 7, 28.

Belleville S., Gilbert B., Fontaine F., Gagnon L., Menard E., Gauthier S. (2006). Improvement of Episodic Memory in Persons with Mild Cognitive Impairment and Healthy Older Adults: Evidence from a Cognitive Intervention Program, Dement Geriatr Cogn Disord, 22(5-6), 486-499.

Blain J. F., Aumont N., Theroux L., Dea D., Poirier J. (2006). A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology, Eur J Neurosci, 24(5), 1245-51.

Blain J. F., Sullivan P. M., Poirier J. (2006). A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice, Neurobiol Dis, 21(3), 505-14.

Carvajal C., Dumont Y., Herzog H., Quirion R. (2006). Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice, J Mol Neurosci, 28(3), 239-45.

Carvajal C., Dumont Y., Quirion R. (2006). Neuropeptide y: role in emotion and alcohol dependence, CNS Neurol Disord Drug Targets, 5(2), 181-95.

Cassidy C. M., Quirion R., Srivastava L. (2006). Blockade of presynaptic voltage-gated calcium channels in the medial prefrontal cortex of neonatal rats leads to post-pubertal alterations in locomotor behavior, Brain Res.

Chakravarty M., Bertrand G., Hodge C. P., Sadikot A. F., Collins D. L. (2006). The creation of a brain atlas for image guided neurosurgery using serial histological data, Neuroimage, 30(2), 359-76. En savoir plus.

Chakravarty M., Sadikot A. F., Mongia S., Bertrand G., Collins D. L. (2006). Towards a multi-modal atlas for neurosurgical planning, Med Image Comput Comput Assist Interv, 9(Pt 2), 389-96. En savoir plus.

Dumont Y., Quirion R. (2006). An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization, Exs(95), 7-33.

Feldman H. H., Gauthier S., Chertkow H., Conn D. K., Freedman M., Chris M. (2006). Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary, Can J Neurol Sci, 33(1), 6-26.

Ferreri F., Agbokou C., Gauthier S. (2006). Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy., J Psychiatry Neurosci, 31, 369-376.

Ferreri F., Agbokou C., Gauthier S. (2006). Recognition and management of neuropsychiatric complications in Parkinson's disease, Cmaj, 175(12), 1545-52.

Gagnon J. F., Petit D., Fantini M. L., Rompre S., Gauthier S., Panisset M., Robillard A., Montplaisir J. (2006). REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease, Sleep, 29(10), 1321-5.